Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Peter Horn

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|February 28, 2015
[In Process Citation]Laila-Yasmin Mani, Uyen Huynh-Do, Michael Peter Horn
Haematologica|November 4, 2006
Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseasesElisabeth Oppliger Leibundgut, Michael Peter Horn, Claudio Brunold, et al.
Haematologica|July 6, 2005
Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reactionElisabeth Oppliger Leibundgut, Claudio Brunold, Dorothee Marti, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|February 28, 2015
[In Process Citation]Laila-Yasmin Mani, Uyen Huynh-Do, Michael Peter Horn
Haematologica|November 4, 2006
Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseasesElisabeth Oppliger Leibundgut, Michael Peter Horn, Claudio Brunold, et al.
Haematologica|July 6, 2005
Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reactionElisabeth Oppliger Leibundgut, Claudio Brunold, Dorothee Marti, et al.
Pageof 1